Universal Corporation logo

Universal Corporation (UVV)

Market Closed
22 Jul, 20:00
NYSE NYSE
$
53. 75
+0.98
+1.8571%
$
1.33B Market Cap
- P/E Ratio
3.28% Div Yield
140,387 Volume
- Eps
$ 52.77
Previous Close
Add Transaction
Day Range
52.97 53.84
Year Range
49.19 59.38
Want to track UVV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Universal Electronics: IoT, AI Exposure, Downsizing, And Cheap

Universal Electronics: IoT, AI Exposure, Downsizing, And Cheap

Universal Electronics Inc. is poised for growth due to the AI and IoT industry boom, with significant demand for its control and sensor technology solutions. UEIC is streamlining operations in Mexico, China, and Vietnam, which could enhance free cash flow and net income growth. The stock repurchase program and partnerships with industry giants like Samsung and Sony bolster the investment case, making UEIC a buy.

Seekingalpha | 1 year ago
Universal Health Services: A Bargain With Medicaid Cuts Fears Baked Into Stock Price

Universal Health Services: A Bargain With Medicaid Cuts Fears Baked Into Stock Price

Universal Health Services (UHS) has shown consistent EPS growth, up 11% annually.  We note recent stock de-rating over Medicaid cut concerns. UHS operates 419 hospitals, with a balanced revenue mix from Acute Care and Behavioral Health, and significant exposure to Medicaid at 25% of total revenue. Despite excellent Q4 results and moderating nursing costs, UHS stock fell due to fears of imminent Medicaid cuts, which are politically contentious and uncertain.

Seekingalpha | 1 year ago
Universal Music Group: Not There Yet, But Heading In The Right Direction

Universal Music Group: Not There Yet, But Heading In The Right Direction

Universal Music Group's Q4 earnings surpassed expectations, but growth remains below company's targets, with volatile profitability. The gap between UMG and Spotify's growth narrowed in Q4, but remains significant, highlighting Spotify's stronger position in the industry. New multi-year agreements with Spotify and other platforms offer potential for improved monetization and growth in 2025.

Seekingalpha | 1 year ago
Universal Health Realty: Attractive Valuation After Recent Underperformance

Universal Health Realty: Attractive Valuation After Recent Underperformance

Universal Health Realty Income Trust is a healthcare REIT focused on medical office buildings and acute care hospitals. The company's portfolio was stable in 2024, with FFO growth driven by lower operating expenses and higher revenues, which helped offset rising interest costs. FFO growth should continue in 2025, with the REIT benefitting from lease escalators and Fed rate cuts.

Seekingalpha | 1 year ago
Universal Health Q4 Earnings Beat on Strong Adjusted Admissions

Universal Health Q4 Earnings Beat on Strong Adjusted Admissions

UHS' fourth-quarter earnings benefit from rising admissions and patient days. Higher expenses partially offset the positives.

Zacks | 1 year ago
Universal Health Services beats fourth-quarter profit estimates on higher hospital admissions

Universal Health Services beats fourth-quarter profit estimates on higher hospital admissions

Hospital operator Universal Health Services beat fourth-quarter profit estimates on Wednesday, driven by robust demand for medical care that required hospital stays.

Reuters | 1 year ago
Universal Health to Report Q4 Earnings: What Do the Estimates Say?

Universal Health to Report Q4 Earnings: What Do the Estimates Say?

UHS' fourth-quarter earnings are likely to have benefited from growing admissions and patient days.

Zacks | 1 year ago
Universal Display Q4 Earnings Beat on Higher Material Sales

Universal Display Q4 Earnings Beat on Higher Material Sales

OLED reports top-line growth year over year, driven by growing traction in the IT, automotive, smartphone and TV end markets.

Zacks | 1 year ago
Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention

Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention

Cidara Therapeutics is leveraging its Cloudbreak platform to develop CD388 for universal influenza prophylaxis. Fortunately, they recently enrolled 5,000 subjects in its Phase 2b trial to assess CD388's safety and efficacy. CD388 inhibits viral replication and activates the immune response, and its mechanism of action actually received the FDA's Fast Track designation.

Seekingalpha | 1 year ago
Universal Health Services: A Quality GARP Company With Significant Upside

Universal Health Services: A Quality GARP Company With Significant Upside

Universal Health Services (UHS) remains a BUY due to stable long-term fundamentals, consistent revenue growth, and improving margins. UHS's strong financial performance, including a 45% increase in adjusted diluted EPS and improved EBITDA margins, underscores its resilience and efficiency. With COVID disruptions over, UHS is poised for 6%-7% long-term growth, supported by robust performance in both acute and behavioral health segments.

Seekingalpha | 1 year ago
Universal Technical Q1 Earnings Beat Estimates, FY25 View Up

Universal Technical Q1 Earnings Beat Estimates, FY25 View Up

UTI's first-quarter fiscal 2025 results indicate growth in new student starts and average full-time active students at UTI and Concorde.

Zacks | 1 year ago
Universal Technical to Report Q1 Earnings: Here's What to Expect

Universal Technical to Report Q1 Earnings: Here's What to Expect

UTI's first-quarter fiscal 2025 results are likely to reflect growth in average full-time active students. Dive in to get a clear picture ahead of earnings.

Zacks | 1 year ago
Loading...
Load More